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Complex 1itochondrial function have been shown to occur with age. In this study we
examined the levels of H2O2 production, in situ mitochondrial membrane potential (Δψm), oxygen
consumption (JO2) and electron transport chain (ETC) enzyme activities in synaptosomes isolated from
rats of two age groups, 6 and 18 months. The rate of H2O2 production in synaptosomes was found to be
higher in the 18-month old group compared to that of 6-month old. Δψm was found to be signiﬁcantly lower
in synaptosomes from the older rats, which also correlated with a reduction in JO2. Measurement of the
individual electron transport chain enzyme activities revealed that reduced complex II/III and complex IV
activities were the possible contributors to the reduced bioenergetic function in synaptosomes from the
older rats. These data suggest that ageing may lead to increased nerve terminal H2O2 production while
simultaneous deleterious effects on bioenergetic function occur in in situ synaptosomal mitochondria. In
addition, Ca2+-independent glutamate release was found to be increased at lower levels of complex I
inhibition in the synaptosomes from older rats, suggesting that reduction of mitochondrial function may
potentiate excitotoxic conditions in the ageing brain.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionMitochondrial dysfunction is thought to bepart of the ageingprocess
in the brain [1,2] and has been observed in the common neurodegen-
erative disorders, Parkinson's disease [3] and Alzheimer's disease [4–6].
Mitochondria are known to be the primary source of reactive oxygen
species (ROS) productionwithin the cell [7], and a commonly held view
is that oxidative stress progressively damages mitochondrial proteins,
lipids and DNA, cumulatively leading to dysfunction, including
depolarisation of Δψm and reduced ATP production [8,9]. Among the
sources of mitochondrial ROS production are the enzymes of electron
transport chain (ETC) that produce O2·− and H2O2, and previous reports
suggest that the levels of H2O2 produced by ETC enzymes increaseswith
age [10–12]. The ETC enzymes are also susceptible to damage by ROS
[13,14], which may lead to further increases in ROS production [15,16].
The relationship between Δψm and the source of H2O2 production
in the brain has been the subject of much debate in the literature.
Studies using isolatedmitochondria have indicated that depolarisation
of Δψm by uncoupling reduces H2O2 production [17–19]. However, it
seems that this phenomenon is not apparent in the more physiologi-
cally relevant synaptosomal model, which examines the effect of Δψm
on H2O2 production in in situ nerve terminal mitochondria [20,21].
Complex I and complex III of the ETC are frequently cited as central
contributors to mitochondrial H2O2 production [22–24] and inhibition
of electron transport at these sites using rotenone and antimycin A,l rights reserved.respectively, decreases Δψm and increases H2O2 production in the
synaptosomal model [3,21,25]. Inhibition of complex IV activity in in
situ mitochondria by KCN and NO has also been shown to induce an
increase in ROS production in astrocytes [26].
In this study, the relationships between H2O2 production, Δψm, JO2
and ETC enzyme activities in isolated whole rat brain nerve terminals
of two age groups (6 months and 18 months) were examined and
compared. It was found that elevated levels of H2O2 production in the
older group parallel reductions in Δψm, JO2 and ETC enzyme activities
in this group compared to the younger group.
2. Methods
2.1. Materials
Chemicals were supplied by Sigma Chemical Co., Poole, Dorset, UK. Amplex Redwas
supplied byMolecular Probes, Eugene, OR, USA. Bio-Rad reagent used for determination
of protein concentration was supplied by Bio-Rad Laboratories GmbH, Munich,
Germany. Male Wistar rats were supplied by the Bioresources Unit, Biochemistry
Department, Trinity College, Dublin.
2.2. Synaptosomal preparation
Two rats of each age group (6 months and 18 months) were killed per preparation
by cervical dislocation and synaptosomes and nonsynaptic mitochondria were isolated
using a discontinuous ﬁcoll gradient (7.5% w/v and 10%w/v), based on themethod of Lai
and Clark [27]. Following isolation, synaptosomes were resuspended in ice cold STE
(0.32 M sucrose, 10 mM Tris, 1 mM EDTA, pH 7.4) and the concentration determined
using the Bradford protein assay. With the exception of respiration experiments (which
were carried out immediately), 1 mg of synaptosomes were added to 1 ml TES buffer
(250 mM sucrose/5 mM TES, pH 7.4), centrifuged at 15,000 g for 10 min and stored as
pellets on ice for use within 2 h of preparation. All experiments were carried out on at
least 3 separate synaptosomal preparations to ensure reproducibility of results.
Fig. 1. Age-related increase in H2O2 production in rat brain synaptosomes. Synapto-
somes (0.5 mg/ml) were incubated with 10 µM rotenone or 1 µM antimycin A where
indicated. A: Experimental traces±SEM from synaptosomes isolated from 6-month
(traces a) and 18-month (traces b) old rats. B: Vmax rates of H2O2 production±SEM for
experiments carried out in triplicate on 3 separate synaptosomal preparations
(⁎=pb0.05).
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H2O2 production was followed using Amplex Red [28]. Synaptosomal pellets were
resuspended in 1 ml of incubation medium (3 mM KCl, 140 mM NaCl, 25 mM Tris–HCl,
10mMglucose, 2 mMMgCl2, pH 7.4). Assay sensitivity was optimised and concentrations
of 50 µM amplex red and 2.5 U/ml horseradish peroxidase were found to give optimum
sensitivity. These concentrations were used for all of the experiments presented in this
study. Fluorescence intensity was followed at λ=585 nm (λ=550 nm emission). The
ﬂuorescence units were calibrated using a standard curve of known amounts of H2O2.
2.4. Measurement of Δψm
In situmitochondrial membrane potential was measured with the JC-1 dye (5,5′6,6′
tetrachloro-1,1′3,3′-tetraethylbenzimidazolylcarbocyanine iodide) using a method
based on Chinopoulos et al. [29]. Synaptosomes were resuspended in incubation
medium (4mg/ml) and loadedwith 6 μM JC-l for 15min at 37 °C. Following threewashes
in incubationmedium, synaptosomeswere diluted to 1mg/ml and 100 µl added to a pre-
prepared 96-well plate containing 100 µl incubation medium plus 2 µl of inhibitor,
where appropriate in ethanol in each well. Each experimental conditionwas carried out
in triplicate on each plate. Fluorescence intensity at λ=590 nm and at λ=535 nm
(λ=490 nm emission) were measured using a SpectraMAX GeminiXS in kinetic mode.
These ﬂuorescence peaks correspond to the ﬂuorescent peaks of the aggregate and
monomer forms of the dye respectively [30]. The ratio of emission at 590 to 535 is a
qualitative measure of in situ mitochondrial membrane potential [31].
2.5. Oxygen consumption
The rate of in situ synaptosomal mitochondrial respiration (JO2) was followed using
Clark-type oxygen electrode with a 7 ml reaction chamber, which was separated from
the electrode by an oxygen-permeable Teﬂon membrane. The rates of oxygen con-
sumption at 37 °Cweremonitored for 6–8min in synaptosomes (1mg/ml) in incubation
medium. The samples were then removed from the chamber and stored at −80 °C for
measurement of ETC enzyme activities.
2.6. Electron transport chain enzyme activity assays
Samples were freeze-fractured 3 times using liquid nitrogen and were assayed on a
Cary UV spectrophotometer at 37 °C. The method used to measure complex I activity
was based on a modiﬁcation of the method of Ragan et al. [32], which involved
monitoring the oxidised of NADH at absorbance λ=340 nm, using decylubiquinone as
the electron acceptor. 100 µg synaptosomal protein was added to a reaction buffer
containing 10 mM MgCl2 and 25 mM potassium phosphate, (pH 7.2) 0.2 mM NADH,
2.5 mg BSA and 1 mM KCN, giving a ﬁnal volume of 1 ml. Decylubiquinone (50 µM) was
added to start the reaction and the rates weremonitored for 7–8min. Rotenone (10 µM)
was added to obtain the rotenone-insensitive rate for a further 5–6 min. For complex I
activity titration with rotenone, 200 µl synaptosomes (0.5 mg/ml) were incubated in
plates at 37 °C with 1 nM–10 µM rotenone for 5 min before being depolarised with 4-
aminopyridine, then incubated for a further 10 and stored at −80 °C. Samples were
assayed as described, except in a SpectraMAX Plus microplate spectrophotometer with
ﬁnal volume of 200 µl.
Complex II/III activity was determined by following the reduction of cytochrome c
at absorbance λ=550 nm. Samples (50 µg of protein) were added to plastic cuvettes
containing buffer 100 mM potassium phosphate, 0.3 mM potassium-EDTA, (pH 7.4),
1 mM KCN and 100 µM cytochrome c with a ﬁnal volume of 1 ml. The reaction was
initiated by the addition of succinate (20 mM). After 7–8 min, myxothiazol (1 µM) was
added to calculate the myxothiazol-insensitive rate.
The activity of complex IV was determined using the method of Wharton and
Tzagoloff [33]. The oxidation of cytochrome c at absorbance λ=550 nm was followed.
Reduced cytochrome c was prepared by the addition a few crystals of ascorbic acid to
oxidised cytochrome c (25 mg/2.5 ml). Excess ascorbic acid was removed by passing the
cytochrome c sample through a PD10 gel ﬁltration column which had been pre-rinsed
with 50ml 1:10 (v/v) dilution of potassiumphosphate buffer (100mM), pH 7.0. The assay
cuvettes contained 50 µM reduced cytochrome c and 100 µl buffer with a ﬁnal volume of
1mlmadeupwithH2O. The reactionwas initiatedby the addition of 50 µg synaptosomal
samples. The results were expressed as ﬁrst order decay rate constants (k).
2.7. Glutamate release
Glutamate release was measured on a SpectraMAX GeminiXS (Molecular Devices, CA)
well plate reader using a continuous ﬂuorimetric assay modiﬁed from that described by
Nicholls et al. [34]. 100 µl of incubationmedium containing 2mMNADP+, 6.32 U L-glutamic
dehydrogenase, was distributed into each of the 96 wells. 2 µl rotenone in ethanol (1 nM–
1 μM ﬁnal concentrations) was added followed by 100 µl of resuspended synaptosomes
(ﬁnal concentration0.5mg/ml) andeachexperimental conditionwas carriedout intriplicate
on each plate. Synaptosomeswere depolarised after 5minwith 1mM4-aminopyridine and
rate of increase in NADPH ﬂuorescence at λ=460 nm emission (λ=340 nm excitation) was
recorded over a 20 min time period at a 32 s interval following depolarisation. Linear rates
were ﬁtted to the traces by the SoftMax Pro program, which accompanies the instrument,
and these rates were calibrated using a standard curve. Enzyme lag [34] was accounted for
when converting rates to pmol/min/mg protein.2.8. Statistical analysis
Results presented are mean±SEM values. Statistical analyses of the results were
determined by doing a one-way ANOVA followed by a Newman–Keuls post-hoc test.
Values of pb0.05 were taken to be signiﬁcant.
3. Results
3.1. H2O2 production in synaptosomes
The rate ofH2O2 productionwas found to occur at a rate of 0.99±0.03
pmol/min/mg protein in synaptosomes isolated from 6-month old rats
(Fig.1). The ratewas found to be approximately 15% higher in 18-month
old synaptosomes (1.13±0.02 pmol/min/mg). The difference in the two
age groups was still evident after inhibition of complex I activity with
10 µM rotenone, which increased the rate in both groups, with a
Fig. 2. Age-related decrease in Δψm in rat brain synaptosomes. Synaptosomes were loaded with JC-1 and resuspended (0.5 mg/ml) for 10 min at 37 °C with reagents where shown.
Fluorescence intensity of the aggregate form of JC-1 (excitation λ=490 nm, emission λ=590) was divided by that of the monomer (excitation λ=490 nm, emission λ=535) under
each condition. Bars shown represent the mean±SEM for experiments carried out in triplicate on 3 separate synaptosomal preparations (⁎⁎⁎=pb0.001).
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rate was found to be 1.27±0.04 pmol/min/mg and 1.49±0.03 pmol/
min/mg in the two respective groups (Fig. 1B), which corresponds to
increases of 29% and 32% compared to controls. Inhibition of complex
III activity with antimycin A has previously been shown to cause
higher rates of H2O2 production in nerve terminals than complex I
inhibition with rotenone [21]. In accordance with this work, it was
found that 1 µM antimycin A caused a 185% increase in H2O2 pro-
duction from6-month old and 164% increase in H2O2 production from
18-month old synaptosomes, giving rates of 2.81±0.06 and 2.99±0.05
pmol/min/mg respectively (Fig. 1B).
3.2. Membrane potential (Δψm)
The ratio of aggregate JC-1 (λ=590 nm) to monomer JC-1
(λ=590 nm) is a qualitative indicator of Δψm in in situ mitochondria, a
high ratio indicating aggregation in the mitochondrial matrix due
to Δψm-driven uptake of the dye [30,31]. A reduction in the ratio
is therefore thought to reﬂect depolarisation of Δψm [30,31]. Δψm
was lower in in situ synaptosomal mitochondria from 18-month old
rats compared to that from 6-month old rats (pb0.001, Fig. 2). In
synaptosomes from 6-month old rats, the ratio was found to be 8.00±
0.29, while in those from 18-month old rats the ratio was found to beFig. 3. Age-related decreases in ETC activities and JO2 in rat brain synaptosomes. Synaptosom
5–6 min before being stored at −20 °C for measurement of electron transport chain enzym
triplicate on 3 separate synaptosomal preparations (⁎⁎⁎=pb0.001, ⁎⁎=pb0.01, ⁎=pb0.057.22±0.22. Inhibition of complex I activity has been proposed to cause
reversal of the complex V (ATP synthase) which results in partial ATP-
dependent maintenance of Δψm by the protons pumped out of the
matrix by complex V [35]. This can be prevented by addition of the
complex V inhibitor, oligomycin, to the medium. 10 µM rotenone signi-
ﬁcantly reduced the ratio in 6- and 18-month old in situ synaptosomal
mitochondria to 3.73±0.15 and 3.44±0.15 respectively. 20 µg/ml
oligomycin with 10 µM rotenone further reduced the Δψm, resulting in
a ratio of 1.57±0.06 in 6-month old and 1.46±0.08 in 18-month old
mitochondria. The ratios which resulted from addition of 1 µM FCCP
were 0.99±0.02 and 0.93±0.05 in the 6- and 18-month old groups,
indicating that Δψm was partially maintained under conditions of
complete inhibition of complex I activity and complex V activity. This is
unsurprising, as proton pumping along the ETC may continue through
complex II. In accordance with this interpretation, combined inhibition
of complex III and complex V using 1 µM antimycin A and 20 µg/ml
oligomycin resulted in total collapse of Δψm by 10 min (ratios of 0.96
±0.02 in 6-month and 0.93±0.04 in 18-month old samples). A level of
Δψmwasmaintainedwith 1 µMantimycin A in 6-month (1.78±0.24) and
18-month (1.63±0.10) samples, indicating that complex V may
partially maintain Δψm under conditions of complex III inhibition
also. Oligomycin itself has previously been shown to hyperpolarise
Δψm in guinea pig synaptosomes [29,35]. However using JC-1, it wases (1mg) were resuspended in a 1 ml oxygen electrode chamber and JO2 followed for
e activity assays. Bars shown represent the mean±SEM for experiments carried out in
).
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membrane potential in both 6-month old and 18-month old rats, giving
ratios of 5.08±0.15 in the younger group and 4.77±0.09 in the older.
3.3. Electron transport chain enzyme activities and JO2
Complex I activity in synaptosomal mitochondria was found to be
45.95±2.10 nmol/min/mg in synaptosomes from 6-month old animals
and was not signiﬁcantly different in those from the 18-month old
group (48.11±2.35 nmol/min/mg, Fig. 3A). However, complex II/III
activity was found to be 13% lower in the older group (68.46±1 nmol/
min/mg, Fig. 3B) compared to 78.29±1.11 nmol/min/mg in the younger
(pb0.001). The rate of complex IV activitywas also found to be lower in
the 18-month old group at 1.73±0.04 k/min/mg, which corresponds to
a rate 16% slower than the 6-month old group (1.46±0.08 k/min/mg,Fig. 4. Age-related differences in complex I control of Ca2+-independent glutamate release
from depolarised synaptosomes. Synaptosomes (0.5 mg/ml) were preincubated with
rotenone (1 nM −10 µM) at 37 °C for 5 min before being depolarised with 1 mM 4-
aminopyridine. Rates of glutamate release at each concentration of rotenonewere plotted
against percent inhibition of complex I activity brought about by that concentration of
rotenone. Sigmoid curves were plotted through the results and the 50% of maximum
glutamate release rate value calculated using a statistical ﬁt. The value was found to
correspond to 49.6±7% in synaptosomes from 6-month old rats (A) and 37.6±1.4% in
synaptosomes from 18-month old rats (B). Points shown represent the mean±SEM for
experiments carried out in triplicate on 4 separate synaptosomal preparations.pb0.01). The rate of oxygen consumption (JO2) by resting synapto-
somes was found to be 3.71±0.13 nmol O2/min/mg in the 6-month
old group, and was 12% lower in the older group at 3.25±0.13 nmol
O2/min/mg (pb0.05, Fig. 3D).
3.4. Glutamate release
We have recently reported that Ca2+-independent glutamate release
from depolarised synaptosomes was increased by partial complex I
inhibitionwith rotenone [36]. In the present study, we used 1 nM–1 µM
rotenone to inhibit complex I activity in a dose-dependent manner and
correlated the inhibition of complex I activity with the release rates of
glutamate in the two age groups. The pattern of release rates over the
titration in synaptosomes from 6-month old rats was similar to that of
our previous experiments [36] and the value at which 50% of maximum
release rate was reached was found to occur at 49.6±7.0% inhibition of
complex I activity (Fig. 4A). It was apparent that the threshold of
complex I inhibitionwas lowered to 37.6±1.4% in the 18-month old rats
before 50% of maximum glutamate release rate was reached. (Fig. 4B).
4. Discussion
The ageing process involves changes to mitochondria including
increased levelsof ROSproductionandreduction inbioenergetic capacity.
This study ﬁnds elevated rates of H2O2 production in synaptosomes from
18-month old rats compared to those from 6-month old. Simultaneously,
Δψm and JO2 were both found to be lower in the older group. Assays of
ETC components revealed compromised complex II/III and complex IV
activity synaptosomes from older animals. These data indicate that an
age-related decline in ETC enzyme activities in nerve terminal
mitochondria may have implications for the ability of the nerve
terminal to maintain adequate energy requirements. In accordance
with the ‘vicious cycle’ theory of oxidative damage [15,16], age-related
increased rates of H2O2 production suggest higher levels of oxidative
stress, which is likely to result in further damaging effects on
mitochondrial function.
Elevated H2O2 production in resting synaptosomes was correlated
with lower Δψm and oxygen consumption rates. The lower level of
respiration may be due to lower complex II/III and complex IV activities
demonstrated by our enzyme assay results. Age-related reductions in
complex II and complex III activities have previously been demonstrated
in mouse brain mitochondria [37], and decreased complex IV activity
with age has been widely reported in rat brain [13,38]. Low-level
pharmacological inhibition of complex II/III and complex IV activities in
synaptic mitochondria has been found to reduce oxygen consumption
and ATP synthesis by up to 15% in synaptosomal mitochondria [39].
Major changes in oxidative phosphorylationparameters occurwhen the
complex activities are inhibited by approximately 60% and above. Under
conditions of reduced electron ﬂow through the electron transport
chain, a reduction in proton pumping out of the mitochondrial matrix
would be expected, resulting in a lower level of Δψm. Whether the
elevated H2O2 production seen in the older group is a cause or effect of
reduced levels of ETC enzyme function is not clear.
In agreement with previous studies, inhibition of complex I
activity with rotenone increased synaptosomal H2O2 production
[21,25] and decreased Δψm [29,35]. The complex I iron–sulphur
centres [40,41] and the ﬂavin moiety [42] have been cited as primary
sites of mitochondrial ROS production. The difference in rate of H2O2
production between the two age groups was not eradicated by
complex I inhibition with rotenone, suggesting that ROS production
at the rotenone-binding site in complex I is not responsible for the
elevated H2O2 production in the older group [43]. Furthermore,
complex I activity was not found to be reduced in the older group,
suggesting no oxidative damage at this site of the ETC in the 18-
month old nerve terminals. Inhibition of complex III using antimycin
A produced higher levels of H2O2 production and completely
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oligomycin. However, at least some of the H2O2 production induced
by this inhibitor is due to reverse electron transport through complex
I, and can be inhibited by rotenone [25]. Complex III has been
implicated in mitochondrial H2O2 production [24] and the rate of
H2O2 production in the older group was not found to be different to
that in the younger group after inhibition at this site of the ETC,
suggesting the antimycin A binding site at complex III may partially
contribute to the elevated level of H2O2 production in the uninhibited
older group. Other mitochondrial enzymes are known to simulta-
neously produce and be susceptible to damage by H2O2 in the nerve
terminal, most notably α-ketoglutarate dehydrogenase [44,45], and
this enzyme may also be among the sources of the excess H2O2
produced in the older synaptosomes.
We have recently reported on how partial reduction of complex I
activity increases Ca2+-independent glutamate release from depo-
larised synaptosomes [36]. In the study, we described how our model
could be relevant to the neurotransmitter release patterns by
glutamatergic nerve terminals during Parkinson's disease, during
which complex I activity has been shown to be reduced [46–48]. Flux
control analysis of mitochondria isolated from rat brain shows that
complex I has a higher ﬂux control coefﬁcient than other ETC com-
ponents in synaptic mitochondria compared to nonsynaptic mito-
chondria. Similarly, when complex I activity is inhibited by 25%, major
changes in oxidative phosphorylation occur, whereas the energy
threshold is 60% in nonsynaptic mitochondria [39,49,50]. An age-
related impairment in ﬂux through the oxidative phosphorylation
system of in situ synaptosomal mitochondria has previously been
demonstrated [51]. Results in our present study indicate that a lower
threshold of inhibition of complex I activity exists in the nerve
terminals of older rats compared to younger rats that may result in
increased release of glutamate following depolarisation. The tighter
control of complex I over glutamate release in the older group suggests
that at the 40% reduction in complex I activity observed in substantia
nigra during Parkinson's disease may lead to higher rates of glutamate
release with age.
In the present study we used rats of two age groups, 6 months
and 18 months. Rats usually reach sexual maturity at 3–4 months and
18-month old rats are considered to be ‘latemiddle aged’ [52]. ‘Old age’
is the highest risk factor for many common chronic neurodegenerative
disorders in which deterioration of mitochondrial function is impli-
cated in their aetiology [6]. Our results show elevated levels of nerve
terminal H2O2 production and reduced level of mitochondrial function
in the ‘late middle aged’ group, indicating that this process may begin
before the onset of ‘old age’. Although the differences between the two
age groups appear to be relatively subtle, they may be among the key
events likely to trigger a ‘vicious cycle’ of mitochondrial deterioration
due to increased levels oxidative stress [15,16]. This increase in ROS
production and associated decline in mitochondrial function may play
a role in the pathogenesis of chronic neurodegenerative disorders such
as Alzheimer's disease and Parkinson's disease [4,6,53].
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